Moderna Asks FDA for Emergency Approval of COVID-19 Vaccine, Second Company to Pass Milestone

Pharmaceutical company Moderna announced Monday that it will submit its coronavirus vaccine to the federal government for emergency use authorization approval.

Moderna said it would ask the Food and Drug Administration (FDA) for approval after its large-scale human trial concluded and showed the company’s vaccine to have an overall efficacy of 94.1%, according to NBC News. The vaccine was found to be 100% effective in preventing severe cases of coronavirus, according to Moderna.

Read More

More Americans Willing to Take Coronavirus Vaccine After Promising Announcements, Poll Shows

More Americans said that they would receive a coronavirus vaccine when available than they did a month ago, according to a new Gallup poll released Tuesday.

Fifty-eight percent of Americans indicated their willingness to take a vaccine in the poll, which surveyed Americans in late October. That number is up eight percent from Gallup’s previous September poll.

Read More

Commentary: A Vaccine from China? No Thanks

While Democrats including presidential candidate and former Vice President Joe Biden, vice presidential candidate Sen. Kamala Harris (Calif.), House Speaker Nancy Pelosi (Calif.), Senate Minority Leader Chuck Schumer (N.Y.), Gov. Andrew Cuomo (N.Y.), Gov. Gavin Newsom (Calif.), Gov. Ned Lamont (Conn.), and Chicago Mayor Lori Lightfoot all publicly question the Trump administration’s ability to facilitate a safe COVID-19 vaccine, could arsonist-turned-firefighter China have the cure we all need?

Read More

Vaccine Expected to be Ready for Vulnerable Population by January, HHS Sec Azar Says

Department of Health and Human Services Sec. Alex Azar said Wednesday that he expects a coronavirus vaccine to be available for vulnerable Americans by January 2021.

The Health and Human Services (HHS) secretary said that vaccines will be immediately be offered to seniors, health care workers and first responders once hospitals are able to administer it, according to The Hill. Sec. Alex Azar’s comments came at press briefing at the Centers for Disease Control and Prevention headquarters.

Read More

Trump Official Says Vaccine Expected Starting in January

A Trump administration official leading the response to the coronavirus pandemic says the U.S. can expect delivery of a vaccine starting in January 2021, despite statements from the president that inoculations could begin this month.

And a growing, bipartisan chorus of lawmakers, experts and public health officials says the country is ill prepared for a projected winter surge of COVID-19.

Read More

Scientists Uneasy as Russia Approves First Coronavirus Vaccine

Russia on Tuesday became the first country to approve a coronavirus vaccine, a move that was met with international skepticism and unease because the shots have only been studied in dozens of people.

President Vladimir Putin announced the Health Ministry’s approval and said one of his two adult daughters already was inoculated. He said the vaccine underwent the necessary tests and was shown to provide lasting immunity to the coronavirus, although Russian authorities have offered no proof to back up claims of safety or effectiveness.

Read More

The Status of the Coronavirus Vaccine Continues to Advance Rapidly

Researchers, governments and pharmaceutical companies worldwide have been working rapidly to develop an effective vaccine against coronavirus, which has infected over 4.5 million and killed over 150,000 people in the United States alone.

Testing has advanced quickly and there’s optimism that a vaccine will be developed before 2021. But there are also concerns that a vaccine won’t be sufficiently stockpiled or efficiently distributed. There’s additional worry that the growing distrust in vaccines will result in large numbers refusing the injection, making it less beneficial.

Read More

US Invests Another $2.1 Billion into a Potential Vaccine

Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of an experimental COVID-19 vaccine to the United States as governments buy up supplies in hopes of securing a candidate that works.

The United States will pay up to $2.1 billion “for development including clinical trials, manufacturing, scale-up and delivery” of the vaccine, the two companies based in Europe said in a statement. Sanofi will get the bulk of the funds.

Read More

Commentary: Extraordinary Claims Require Extraordinary Evidence

Dr. Carl Sagan was one of the premier scientists when it came to trying to bridge the gap of hard science with general public understanding. In the process, his personal enthusiasm for the wonder of science became evident to all. He also understood that science could be hijacked and that the highest standards of evidence were required when fantastic claims were being made.

Read More

National Security Adviser ‘Wouldn’t Be Surprised’ if China Steals US Coronavirus Vaccine

by Jason Hopkins   White House National Security Adviser Robert O’Brien on Sunday suggested that the Chinese Community Party would very likely try to steal American developments on a coronavirus vaccine. During an appearance on CBS’s “Face the Nation,” O’Brien predicted that the United States would be the first country…

Read More

Keith Ellison Asked Trump Admin to End Ban on Using Aborted Fetal Tissue for Research

Attorney General Keith Ellison said a federal ban on using aborted fetal tissue for research is “hampering” the nation’s ability to respond to COVID-19 in a letter sent to the Trump administration.

Read More

Commentary: America Needs a Manhattan Project to Create a Coronavirus Vaccine

There are only two ways human action can get the SARS-CoV-2 virus permanently behind us and return to normal life: we either develop a knock-out therapy that kills the virus dead in people who have contracted it, like powerful antibiotics do with bacterial infections, or we need to develop herd immunity. Without one of those, we are left hoping that the virus simply burns itself out and disappears. That would be foolish. But a knockout drug—a cure—is highly unlikely. There is no such drug for the seasonal flu or for the rhinoviruses that cause the common cold. So while effective therapies should be a part of the strategy to combat the ill effects of this virus, and sensible precautions like masks can prevent its spread, the only way to permanently defeat it is through herd immunity.

Read More

Richard Grenell Denies Reports Suggesting Trump Wants Exclusive Access to a German Vaccine

U.S. ambassador to Germany Richard Grenell told his Twitter followers Sunday afternoon that the a report from Welt am Sonntag German newspaper discussing Trump’s offer is “not true.”

“The Welt story was wrong. But Business Insider, Reuters and others went with it anyway despite not having their own sources. Now everyone is back peddling,” Grenell said in his Sunday afternoon tweet.

Read More

Deputy UN Chief: Fight Against Tuberculosis Drastically Underfunded

Tuberculosis (TB) is a vicious epidemic that is drastically underfunded. That was the takeaway message from the first high-level meeting focused on the infectious disease at the U.N. General Assembly in New York. Amina Mohammad, U.N. deputy secretary-general, said the disease is fueled by poverty, inequality, migration and conflict, and…

Read More